Strategic Partners
We are proud to include highly successful pharma companies, real estate developers, research institutions and biotech incubators among our partners. They provide us and our portfolio companies with unique expertise and synergies
BRANDYWINE REALTY TRUST
Brandywine Realty Trust is a self-administered and self-managed real estate investment trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of an urban, town center and transit-oriented portfolio of office and mixed-use properties. It is one of the largest, publicly traded, full-service, integrated real estate companies in the United States with a core focus in the Philadelphia, Austin and Washington, D.C. markets. For more than 25 years, Brandywine’s commitment to innovation, integrity, quality, and community has translated into not only business success, but also healthier and more vibrant communities.
DAIICHI SANKYO
Daiichi Sankyo is an innovative global healthcare company contributing to the sustainable development of society that discovers, develops, and delivers new standards of care to enrich the quality of life around the world. With a legacy of innovation since 1899 and a presence in 32 countries, Daiichi Sankyo and its 19,700+ employees leverage world-class science and technology to create new modalities and innovative medicines for people with cancer, cardiovascular, and other diseases with high unmet medical need. For more information, please visit www.DaiichiSankyo.com
BARUCH S. BLUMBERG INSTITUTE
An independent, nonprofit research organization, the Blumberg Institute was launched in 2003 by the Hepatitis B Foundation to advance its research mission. Today, the Institute is one of the nation’s leading centers for translational research in hepatitis B and liver cancer. The Institute supports drug discovery, biomarker discovery and translational biotechnology around common research themes such as chronic hepatitis, liver disease and liver cancer in an environment conducive to interaction, collaboration and focus.
THE HEPATITIS B FOUNDATION
The Foundation is the nation’s leading nonprofit organization solely dedicated to finding a cure for hepatitis B and improving the quality of life for those affected worldwide through research, education and patient advocacy. Founded in 1991, the Hepatitis B Foundation is based in Doylestown, PA, with offices in Washington, D.C., and Philadelphia.
B+LABS
B+Labs is a newly-constructed, state-of-the art, 50,000 sqft life sciences incubator in the heart of University City, Philadelphia, in an area teeming with top talent and renowned healthcare and academic institutions. Powered by the Pennsylvania Biotechnology Center (PABC), it provides flexible, plug & play lab and research space, within a specialized network of resources, programming, and expertise. B+Labs is part of Brandywine's Life Science ecosystem, which provides life science companies with the platform to grow into bigger users in the region, with flexibility for seamless expansion into larger graduation space.
PENNSYLVANIA BIOTECHNOLOGY CENTER
Located in Doylestown, PA, in the heart of the Philadelphia-New Jersey pharma belt, the Pennsylvania Biotechnology Center (PABC) is a nonprofit life sciences incubator-accelerator offering state-of-the-art laboratory and office space to 40+ early stage biotech companies. The PABC uses a highly successful services-based approach to nurture and guide its member companies to success, advancing biotechnology, maximizing synergies among nonprofit scientists and their commercial colleagues, and launching new ideas and discoveries. To date, more than 75 companies have called PABC their home. PABC tenants account for 17% of all NIH SBIR grants awarded in Pennsylvania and over the years have created billions of dollars in market value from IPOs, acquisitions and commercial valuations.
We are committed to working closely with our partners to meet our investment returns goals and their strategic objectives.
